Alnylam Pharmaceuticals, Inc. (ALNY)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 02:22PM EDT. Market open.
| Previous close | 149.96 |
| Open | 150.80 |
| Bid | 152.33 x 100 |
| Ask | 152.74 x 100 |
| Day's range | 147.29 - 153.85 |
| 52-week range | 141.98 - 218.88 |
| Volume | |
| Avg. volume | 837,483 |
| Market cap | 19.302B |
| Beta (5Y monthly) | 0.40 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Compared to Estimates, Alnylam (ALNY) Q1 Earnings: A Look at Key Metrics
Although the revenue and EPS for Alnylam (ALNY) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
- Zacks
Alnylam Pharmaceuticals (ALNY) Reports Q1 Loss, Tops Revenue Estimates
Alnylam (ALNY) delivered earnings and revenue surprises of 78.67% and 17.39%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
- Zacks
Gear Up for Alnylam (ALNY) Q1 Earnings: Wall Street Estimates for Key Metrics
Beyond analysts' top -and-bottom-line estimates for Alnylam (ALNY), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended March 2024.
© 2024 Yahoo. All rights reserved.